US FDA Exploring Consortium To Develop Treatments For ‘Economically Infeasible’ Cancer Indications

 
• By Derrick Gingery
  
drug development
The public-private consortium could represent a substantial expansion of the FDA's Project Catalyst. • Source: Shutterstock

More from R&D

More from Pink Sheet